The Botswana Medicines Regulatory Authority (BoMRA) is a new authority that is set up under the Medicines and Related Substances Act (MRSA) of 2013 and was established by the Botswana Government to regulate the supply chain of medicines and related substances, cosmetics and medical devices in order to ensure their quality, safety and efficacy. https://bomra.developer.co.bw/wp-content/uploads/2022/07/capsule-pill.webp
The Botswana Medicines Regulatory Authority (BoMRA) will be conducting virtual stakeholder engagements to discuss the MRS ACT, Medical Devices Regulatory Framework, Medical Devices Exemptions and update on Listing exercise. The roles played by Healthcare Facilities and Procurement Entities in ensuring that safe Medical Devices and IVDs are imported into the country, services availed by BoMRA […]
Botswana Medicines Regulatory Authority (BoMRA) would like to inform relevant stake holders that; that all Covid-19 related medical devices and IVDs should go through an exemption process before they can be imported into the country.
The Botswana Medicines Regulatory Authority would like to advise all our valued stakeholders that our offices will be closed from Friday 02nd July- Monday OSth July 2021.
The Botswana Medicines Regulatory Authority (BoMRA) wishes to inform the public, healthcare practitioners, importers, and distributors that ALL Grand-Pa pain relief products (powder and tablets ) remain suspended from registration and therefore are not allowed in Botswana.
Please be informed that the VET stakeholder engagement that was scheduled for the 14-15 of June 2021 has been postponed to the 12-13 July 2021.
Botswana Medicines Regulatory Authority (BoMRA) would like to inform its valued clients, stakeholders and the general public that the Department of Licensing and Enforcement will be relocating to a new site effective 1st May 2021. The Department will be housed, at Plot 145, Unit 9; Block B First Floor Gaborone International Finance Park area
The Department of Product Evaluation & Registration at BoMRA will conduct virtual stakeholder sessions to discuss the listing requirements for medical devices, including In-Vitro Diagnostics (IVDs) devices.
BoMRA is mandated to regulate cosmetics to ensure that they conform to the set standards of safety, quality, and efficacy. The Authority (BoMRA) is calling on all entities trading and using cosmetics in their practices/ occupations to submit their contact details for ease of communication on regulatory updates.
The Botswana Medicines Regulatory Authority (BoMRA) is concerned about the continued presence, increased reporting and occasional confiscation of the following unregistered products in the Botswana Market.